新型长链非编码rna LINC01093和MYLK-AS1可作为肝细胞癌的潜在诊断和预后生物标志物

IF 2.6 4区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Yanming Qin, Xin Tu, Meifang Huang, Caifang Ma, Qiongqing Huang, Qiqi Huang, Hong Shu, Chao Ou
{"title":"新型长链非编码rna LINC01093和MYLK-AS1可作为肝细胞癌的潜在诊断和预后生物标志物","authors":"Yanming Qin,&nbsp;Xin Tu,&nbsp;Meifang Huang,&nbsp;Caifang Ma,&nbsp;Qiongqing Huang,&nbsp;Qiqi Huang,&nbsp;Hong Shu,&nbsp;Chao Ou","doi":"10.1089/dna.2022.0566","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is one of the most fatal human malignancies worldwide. In this research, we aimed to identify long noncoding RNAs (lncRNAs) as biomarkers for HCC diagnosis and prognosis. lncRNA expression profiles were obtained from Gene Expression Omnibus and The Cancer Genome Atlas databases. The differentially expressed lncRNAs between HCC and adjacent tissues were analyzed with bioinformatic tools. Four lncRNAs with area under the curve of the receiver operating characteristic curve >0.9 were selected from both datasets. Univariate and Kaplan-Meier analyses were performed to obtain <i>LINC01093</i>, <i>MYLK-AS1</i>, and <i>MCM3AP-AS1</i> as the optimal diagnostic and prognostic biomarkers. Finally, qPCR confirmed that <i>LINC01093</i> and <i>MYLK-AS1</i> were significantly differentially expressed in HCC and adjacent normal tissues. In general, we demonstrated that novel lncRNAs, <i>LINC01093</i> and <i>MYLK-AS1</i>, could be used as potential diagnostic and prognostic biomarkers for HCC.</p>","PeriodicalId":11248,"journal":{"name":"DNA and cell biology","volume":"42 8","pages":"488-497"},"PeriodicalIF":2.6000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Novel Long Noncoding RNAs, <i>LINC01093</i> and <i>MYLK-AS1</i>, Serve as Potential Diagnostic and Prognostic Biomarkers or Hepatocellular Carcinoma.\",\"authors\":\"Yanming Qin,&nbsp;Xin Tu,&nbsp;Meifang Huang,&nbsp;Caifang Ma,&nbsp;Qiongqing Huang,&nbsp;Qiqi Huang,&nbsp;Hong Shu,&nbsp;Chao Ou\",\"doi\":\"10.1089/dna.2022.0566\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hepatocellular carcinoma (HCC) is one of the most fatal human malignancies worldwide. In this research, we aimed to identify long noncoding RNAs (lncRNAs) as biomarkers for HCC diagnosis and prognosis. lncRNA expression profiles were obtained from Gene Expression Omnibus and The Cancer Genome Atlas databases. The differentially expressed lncRNAs between HCC and adjacent tissues were analyzed with bioinformatic tools. Four lncRNAs with area under the curve of the receiver operating characteristic curve >0.9 were selected from both datasets. Univariate and Kaplan-Meier analyses were performed to obtain <i>LINC01093</i>, <i>MYLK-AS1</i>, and <i>MCM3AP-AS1</i> as the optimal diagnostic and prognostic biomarkers. Finally, qPCR confirmed that <i>LINC01093</i> and <i>MYLK-AS1</i> were significantly differentially expressed in HCC and adjacent normal tissues. In general, we demonstrated that novel lncRNAs, <i>LINC01093</i> and <i>MYLK-AS1</i>, could be used as potential diagnostic and prognostic biomarkers for HCC.</p>\",\"PeriodicalId\":11248,\"journal\":{\"name\":\"DNA and cell biology\",\"volume\":\"42 8\",\"pages\":\"488-497\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"DNA and cell biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1089/dna.2022.0566\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"DNA and cell biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/dna.2022.0566","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 1

摘要

肝细胞癌(HCC)是世界上最致命的人类恶性肿瘤之一。在本研究中,我们旨在鉴定长链非编码rna (lncRNAs)作为HCC诊断和预后的生物标志物。lncRNA表达谱从Gene expression Omnibus和The Cancer Genome Atlas数据库中获得。利用生物信息学工具分析HCC与邻近组织之间lncrna的差异表达。从两个数据集中选择4个接受者工作特征曲线下面积>0.9的lncrna。通过单因素分析和Kaplan-Meier分析,获得LINC01093、mylar - as1和MCM3AP-AS1作为最佳诊断和预后生物标志物。最后,qPCR证实了LINC01093和MYLK-AS1在HCC和邻近正常组织中的表达存在显著差异。总的来说,我们证明了新的lncrna, LINC01093和MYLK-AS1,可以用作HCC的潜在诊断和预后生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Novel Long Noncoding RNAs, LINC01093 and MYLK-AS1, Serve as Potential Diagnostic and Prognostic Biomarkers or Hepatocellular Carcinoma.

Hepatocellular carcinoma (HCC) is one of the most fatal human malignancies worldwide. In this research, we aimed to identify long noncoding RNAs (lncRNAs) as biomarkers for HCC diagnosis and prognosis. lncRNA expression profiles were obtained from Gene Expression Omnibus and The Cancer Genome Atlas databases. The differentially expressed lncRNAs between HCC and adjacent tissues were analyzed with bioinformatic tools. Four lncRNAs with area under the curve of the receiver operating characteristic curve >0.9 were selected from both datasets. Univariate and Kaplan-Meier analyses were performed to obtain LINC01093, MYLK-AS1, and MCM3AP-AS1 as the optimal diagnostic and prognostic biomarkers. Finally, qPCR confirmed that LINC01093 and MYLK-AS1 were significantly differentially expressed in HCC and adjacent normal tissues. In general, we demonstrated that novel lncRNAs, LINC01093 and MYLK-AS1, could be used as potential diagnostic and prognostic biomarkers for HCC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
DNA and cell biology
DNA and cell biology 生物-生化与分子生物学
CiteScore
6.60
自引率
0.00%
发文量
93
审稿时长
1.5 months
期刊介绍: DNA and Cell Biology delivers authoritative, peer-reviewed research on all aspects of molecular and cellular biology, with a unique focus on combining mechanistic and clinical studies to drive the field forward. DNA and Cell Biology coverage includes: Gene Structure, Function, and Regulation Gene regulation Molecular mechanisms of cell activation Mechanisms of transcriptional, translational, or epigenetic control of gene expression Molecular Medicine Molecular pathogenesis Genetic approaches to cancer and autoimmune diseases Translational studies in cell and molecular biology Cellular Organelles Autophagy Apoptosis P bodies Peroxisosomes Protein Biosynthesis and Degradation Regulation of protein synthesis Post-translational modifications Control of degradation Cell-Autonomous Inflammation and Host Cell Response to Infection Responses to cytokines and other physiological mediators Evasive pathways of pathogens.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信